摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

HN=2,5-Ph2C3N2H4 | 4044-91-1

中文名称
——
中文别名
——
英文名称
HN=2,5-Ph2C3N2H4
英文别名
1,3-diphenyl-imidazolidin-2-ylideneamine;1,3-diphenyl-imidazolidin-2-one-imine;1,3-Diphenyl-imidazolidin-2-on-imin;2-Imino-1,3-diphenyl-imidazolidin;1,3-diphenylimidazolidin-2-imine
HN=2,5-Ph2C3N2H4化学式
CAS
4044-91-1
化学式
C15H15N3
mdl
——
分子量
237.304
InChiKey
YCQASTCWGZVWEC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    162 °C
  • 沸点:
    346.1±25.0 °C(Predicted)
  • 密度:
    1.14±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.7
  • 重原子数:
    18
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.13
  • 拓扑面积:
    30.3
  • 氢给体数:
    1
  • 氢受体数:
    1

反应信息

  • 作为反应物:
    描述:
    (五甲基环戊二烯基)三氯化钛(IV)HN=2,5-Ph2C3N2H4正丁基锂 作用下, 以 正己烷甲苯 为溶剂, 反应 3.0h, 以48%的产率得到(pentamethylcyclopentadienyl)*TiCl2[1,3-(C6H5)2(CH2N)2C]N
    参考文献:
    名称:
    Cp * TiCl 2 [1,3-R 2(CH 2 N)2 C N]型1,3-咪唑啉-2-亚氨基配体的半钛茂烃的合成:乙烯(共)聚合中的高活性催化剂前体†
    摘要:
    一系列含有1,3-咪唑啉-2-亚氨基配体类型Cp * TiCl 2 [1,3-R 2(CH 2 N)2 C N]的一系列(五甲基环戊二烯基)二氯化钛(IV)络合物[R = t Bu(1a),环己基(Cy,1b),C 6 H 5(1c),2,6-Me 2 C 6 H 3(1d),2,6- i Pr 2 C 6 H 3(1e)]具有已经准备好,结构为1b–e已经通过X射线晶体学确定。这些络合物,特别是1d,e在存在MAO的情况下不仅对乙烯聚合反应而且对乙烯/ 1-己烯共聚反应(对每摩尔Ti / h的活性为482 000-1 750 000 kg聚合物/ mol)具有显着的催化活性。
    DOI:
    10.1039/c5ra11402k
  • 作为产物:
    描述:
    N,N'-diphenyl-N,N'-ethanediyl-di-carbamonitrile 在 盐酸 作用下, 生成 HN=2,5-Ph2C3N2H4
    参考文献:
    名称:
    Traube,W.; v. Wedelstaedt, Chemische Berichte, 1900, vol. 33, p. 1385
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Effect of ligand substituents in olefin polymerisation by half-sandwich titanium complexes containing monoanionic iminoimidazolidide ligands–MAO catalyst systems
    作者:Kotohiro Nomura、Hiroya Fukuda、Shohei Katao、Michiya Fujiki、Hyun Joon Kim、Dong-Hyun Kim、Shu Zhang
    DOI:10.1039/c1dt10467e
    日期:——
    Various half-sandwich titanium complexes containing iminoimidazolidide ligands, CpTiCl2[1,3-R2(CH2N)2CN] (1a–d) [R = Ph (a), 2,6-Me2C6H3 (b), cyclohexyl (c), tBu (d)], have been employed as the catalyst precursors for ethylene polymerisation, syndiospecific styrene polymerisation, and copolymerisation of ethylene with 1-hexene in the presence of MAO cocatalyst; 1d showed the highest catalytic activity for ethylene polymerisation whereas 1b showed the highest activity for syndiospecific styrene polymerisation.
    含亚胺基咪唑啉酮配体的各类半夹心钛配合物,CpTiCl2[1,3-R2(CH2N)2CN] (1a-d) [R=苯基(a),2,6-二甲基苯(b),环己基(c),叔丁基(d)],已被用作乙烯聚合、间同规聚合苯乙烯及在MAO助催化剂存在下乙烯与1-己烯共聚的催化剂前体;对于乙烯聚合,化合物1d显示最高的催化活性,而对于间同规聚合苯乙烯,化合物1b显示最高的活性。
  • Synthesis and structure-activity relationships of N,N'-di-o-tolylguanidine analogs, high-affinity ligands for the haloperidol-sensitive .sigma. receptor
    作者:Michael W. Scherz、Michelle Fialeix、James B. Fischer、N. Laxma Reddy、Alfred C. Server、Mark S. Sonders、Barbara C. Tester、Eckard Weber、Scott T. Wong、John F. W. Keana
    DOI:10.1021/jm00171a016
    日期:1990.9
    2-CH3C6H5). Replacement of one or both aryl rings with certain saturated carbocycles (e.g. cyclohexyl, norbornyl, or adamantyl) leads to a significant increase in affinity. By combining the best aromatic and best saturated carbocyclic substituents in the same molecule, we arrived at some of the most potent sigma ligands described to date (e.g. N-exo-2-norbornyl-N'-(2-iodophenyl)guanidine, IC50 = 3 nM vs [3H]-3)
    着眼于新型非典型抗精神病药的开发,我们研究了氟哌啶醇敏感的sigma受体的N,N'-二-邻甲苯基胍(DTG,3)及其同类物的结构亲和力关系。合成了许多DTG类似物,并在豚鼠脑膜匀浆的体外放射性配体置换实验中使用了高sigma特异性放射性配体[3H] -3和[3H]-(+)-3-(3-羟苯基)进行了评估。 -N-(1-丙基)哌啶和苯环利定(PCP)受体特异性化合物[3H] -N- [1-(2-噻吩基)-环己基]哌啶和[3H]-(+)-5-甲基-10 ,11-二氢-5H-二苯并[a,d]环庚烯-5,10-亚胺。N,N'-二芳基胍对sigma受体的亲和力随邻位取代基的体积比C2H5大而增加。疏水取代基通常优于类似位置的亲水取代基。此外,电子中性取代基优于强电子给体或吸电子基团。只要胍的至少一侧带有优选基团(例如2-CH 3 C 6 H 5),通常就可以保持与σ受体的显着结合。用某些饱和的碳环(例
  • Synthesis and Structural Analysis of (Imido)vanadium(V) Dichloride Complexes Containing Imidazolin-2-iminato- and Imidazolidin-2-iminato Ligands, and their Use as Catalyst Precursors for Ethylene (Co)polymerization
    作者:Kotohiro Nomura、Bijal Kottukkal Bahuleyan、Shu Zhang、Prabhuodeyara M. Veeresha Sharma、Shohei Katao、Atsushi Igarashi、Akiko Inagaki、Matthias Tamm
    DOI:10.1021/ic402747d
    日期:2014.1.6
    copolymerization of ethylene with norbornene (NBE), affording ultrahigh molecular weight copolymers with uniform molecular weight distributions. The activities were affected by the imido ligand as well as by the substituents in the anionic ligand, and the 2,6-iPr2C6H3 analogues (especially 2c and 4c) showed the higher activities. The complexes 2c and 4c also showed high activities with efficient comonomer incorporation
    一系列含有(V)(NR')Cl 2(L)[1']的1,3-咪唑啉-2-亚氨基或1,3-咪唑啉-2-亚氨基配体的二氯化(亚氨基)钒(V)配合物= 2,6-ME 2 ç 6 ħ 3,L = 1,3-R 2(CHN)2 C = N(1A - ç,ë)或1,3--R 2(CH 2 N)2 C = N (2a – d),R = t Bu(a),2,6-Me 2 C 6 H 3(b),2,6- i Pr 2 C6 H 3(c),C 6 H 5(d),2,6-(Ph 2 CH)2 -4-MeC 6 H 2(e);L = 1,3-(2,6- i Pr 2 C 6 H 3)2(CHN)2 C 2N,R'= 1-金刚烷基(Ad,3c),C 6 H 5(4c);L = 1,3-(2,6- i Pr 2 C 6 H 3)2(CH 2 N)2 C = N,R'=广告(图5c)],制备和表征。通过X射线晶体学测定1a
  • [EN] OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF<br/>[FR] COMPOSITIONS D'OLIGONUCLÉOTIDES ET PROCÉDÉS ASSOCIÉS
    申请人:WAVE LIFE SCIENCES LTD
    公开号:WO2022099159A1
    公开(公告)日:2022-05-12
    Among other things, the present disclosure provides oligonucleotides and compositions thereof. In some embodiments, provided oligonucleotides and compositions are useful for adenosine modification. In some embodiments, the present disclosure provides methods for treating various conditions, disorders or diseases that can benefit from adenosine modification.
    除其他事项外,本公开提供寡核苷酸及其组合物。在某些实施例中,提供的寡核苷酸及其组合物对腺苷修饰有用。在某些实施例中,本公开提供了治疗各种需要腺苷修饰的疾病、疾病或病症的方法。
  • Synthesis and structural analysis of half-titanocenes containing 1,3-imidazolidin-2-iminato ligands: Effect of ligand substituents in ethylene (co)polymerization
    作者:Kotohiro Nomura、Hiroya Fukuda、Hideshi Matsuda、Shohei Katao、Srisuda Patamma
    DOI:10.1016/j.jorganchem.2015.04.028
    日期:2015.12
    A series of half-titanocenes containing 1,3-imidazolidin-2-iminato ligands of type, (tert-BuC5H4)TiCl2[1,3-R-2(CH2N)(2)C=N] [R = Bu-t (2a), cyclohexyl (Cy, 2b), C6H5 (2c), 2,6-Me2C6H3 (2d), 2,6-(Pr2C6H3)-Pr-i (2e)] have been prepared and structures of 2a-d have been determined by X-ray crystallography. Complex 2a showed higher catalytic activity than the Cp analogue (1a) for ethylene polymerization but showed low catalytic activity in ethylene/1-hexene copolymerization under the similar conditions; the 2,6-Me2C6H3 analogue (2d) showed moderate catalytic activity for the ethylene/1-hexene copolymerization. The copolymerization with styrene proceeded in a living manner under certain conditions, whereas the other complexes (2a-c) including the Cp analogues, CpTiCl2[1,3-R-2(CH2N)(2)C=N] (1a-d), showed low catalytic activities and/or afforded a mixture of polymers (copolymer, and homopolymers) under the similar conditions. (C) 2015 Elsevier B.V. All rights reserved.
查看更多

同类化合物

(R)-4-异丙基-2-恶唑烷硫酮 麻黄恶碱 顺-八氢-2H-苯并咪唑-2-酮 顺-1-(4-氟苯基)-4-[1-(4-氟苯基)-4-羰基-1,3,8-三氮杂螺[4.5]癸-8-基]环己甲腈 非达司他 降冰片烯缩醛3-((1S,2S,4S)-双环[2.2.1]庚-5-烯-2-羰基)恶唑烷-2-酮 阿齐利特 阿那昔酮 阿洛双酮 阿帕鲁胺 阿帕他胺杂质2 铟烷-2-YL-甲基胺盐酸 钠2-{[4,5-二羟基-3-(羟基甲基)-2-氧代-1-咪唑烷基]甲氧基}乙烷磺酸酯 重氮烷基脲 詹氏催化剂 解草恶唑 解草噁唑 表告依春 螺莫司汀 螺立林 螺海因氮丙啶 螺[1-氮杂双环[2.2.2]辛烷-8,5'-咪唑烷]-2',4'-二酮 苯甲酸,4-氟-,2-[5,7-二(三氟甲基)-1,8-二氮杂萘-2-基]-2-甲基酰肼 苯氰二硫酸,1-氰基-1-甲基-4-氧代-4-(2-硫代-3-噻唑烷基)丁酯 苯妥英钠杂质8 苯妥英-D10 苯妥英 苯基硫代海因半胱氨酸钠盐 苯基硫代乙内酰脲-谷氨酸 苯基硫代乙内酰脲-蛋氨酸 苯基硫代乙内酰脲-苯丙氨酸 苯基硫代乙内酰脲-色氨酸 苯基硫代乙内酰脲-脯氨酸 苯基硫代乙内酰脲-缬氨酸 苯基硫代乙内酰脲-异亮氨酸 苯基硫代乙内酰脲-天冬氨酸 苯基硫代乙内酰脲-亮氨酸 苯基硫代乙内酰脲-丙氨酸 苯基硫代乙内酰脲-D-苏氨酸 苯基硫代乙内酰脲-(NΕ-苯基硫代氨基甲酰)-赖氨酸 苯基乙内酰脲-甘氨酸 苏氨酸-1-(苯基硫基)-2,4-咪唑烷二酮(1:1) 色氨酸标准品002 膦酸,(2-羰基-1-咪唑烷基)-,二(1-甲基乙基)酯 脱氢-1,3-二甲基尿囊素 聚(d(A-T)铯) 羟甲基-5,5-二甲基咪唑烷-2,4-二酮 羟基香豆素 美芬妥英 美芬妥英